JPS57114520A - Antiarteriosclerotic agent - Google Patents

Antiarteriosclerotic agent

Info

Publication number
JPS57114520A
JPS57114520A JP11749481A JP11749481A JPS57114520A JP S57114520 A JPS57114520 A JP S57114520A JP 11749481 A JP11749481 A JP 11749481A JP 11749481 A JP11749481 A JP 11749481A JP S57114520 A JPS57114520 A JP S57114520A
Authority
JP
Japan
Prior art keywords
agent
mannoside
men
methyl ester
active constituent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP11749481A
Other languages
Japanese (ja)
Other versions
JPS5924136B2 (en
Inventor
Chikao Yoshikumi
Minoru Ohara
Masanori Ubusawa
Takami Fujii
Yoshio Omura
Takao Ando
Kenichi Matsunaga
Fumio Hirose
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kureha Corp
Original Assignee
Kureha Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kureha Corp filed Critical Kureha Corp
Priority to JP11749481A priority Critical patent/JPS5924136B2/en
Publication of JPS57114520A publication Critical patent/JPS57114520A/en
Publication of JPS5924136B2 publication Critical patent/JPS5924136B2/en
Expired legal-status Critical Current

Links

Abstract

PURPOSE: An antiarteriosclerotic agent, containing anthranilic methyl ester-N-D- mannoside as an active constituent, having a low antimicrobial activity, and administrable for a long term without exhibiting the mutagenicity and affecting the cellular and body fluid immunity.
CONSTITUTION: An antiarteriosclerotic agent containing anthranilic methyl ester- N-D-mannoside as an active constituent. The agent is administered orally or parenterally to men and animals in the dosage form of powder, tablet, capsule, suppository, injection, etc., preferably orally. The daily dose per kg body weight for men is preferably 1W250mg for the oral administration and 0.1W10mg for the parenteral administration in one W divided four fractions.
COPYRIGHT: (C)1982,JPO&Japio
JP11749481A 1981-07-27 1981-07-27 Antiarteriosclerotic agent Expired JPS5924136B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP11749481A JPS5924136B2 (en) 1981-07-27 1981-07-27 Antiarteriosclerotic agent

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP11749481A JPS5924136B2 (en) 1981-07-27 1981-07-27 Antiarteriosclerotic agent

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP4201478A Division JPS54135231A (en) 1978-04-06 1978-04-10 Cardio-vasocular medicine

Publications (2)

Publication Number Publication Date
JPS57114520A true JPS57114520A (en) 1982-07-16
JPS5924136B2 JPS5924136B2 (en) 1984-06-07

Family

ID=14713113

Family Applications (1)

Application Number Title Priority Date Filing Date
JP11749481A Expired JPS5924136B2 (en) 1981-07-27 1981-07-27 Antiarteriosclerotic agent

Country Status (1)

Country Link
JP (1) JPS5924136B2 (en)

Also Published As

Publication number Publication date
JPS5924136B2 (en) 1984-06-07

Similar Documents

Publication Publication Date Title
IL80149A (en) Pharmaceutical compositions containing toluidide derivatives against graft-versus-host diseases and autoimmune diseases
CA2038672A1 (en) Dosage form for delivering drug to the intestine
IE34746L (en) 2-(n-allyl-n-arylamino)-imidazolines
JPS57114520A (en) Antiarteriosclerotic agent
JPS57114512A (en) Antidia beticagent comprising (3-dimethyl-carbamoxy- phenyl)trimethyl ammonium derivative
JPS57114519A (en) Antiarteriosclerotic agent
JPS5793913A (en) Enhancing agent for spermous vital power
JPS54132239A (en) Anti-tumor agent
JPS5675425A (en) Antitumor agent containing procainamide hydrochloride
JPS5675426A (en) Anti-inflammatory agent containing procainamide hydrochloride
JPS5675428A (en) Hypoglycemic agent containing procainamide hydrochloride
JPS57114518A (en) Hypotensive agent
GB950162A (en) Medicines for the treatment of hepatic disorders
JPS57114515A (en) Antipyr eticand analgesic comprising (3-dimethylcarbam- oxyphenyl)trimethyl ammonium derivative
JPS57114514A (en) Antiphlogistic comprising (3-dimethylcarbamoxyphenyl) trimethyl ammonium derivative
JPS5759808A (en) Remedy and preventive for digestive ulcer
JPS57114513A (en) Drug against arterioscleriosis comprising (3-dimethylca- rbamoxyphenyl)trimethyl ammonium derivative
JPS5498791A (en) Anti-asthmatic drug
JPS5498339A (en) Carcinostatic agent
JPS57128625A (en) Carcinostatic
JPS57167912A (en) Antitumor agent
JPS54135231A (en) Cardio-vasocular medicine
JPS5758619A (en) Carcinostatic agent
JPS57112327A (en) Antidiabetic agent comprising 2,3-dihydroxypropyl ester of n-(7-chloro-4-quinolyl)anthranillic acid
JPS5759809A (en) Cardiotonic agent